Linked Data API

Show Search Form

Search Results

422660
registered interest false more like this
date less than 2015-10-20more like thismore than 2015-10-20
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Pregnancy: Mental Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what the net change has been in the number of inpatient perinatal mental health beds since 2010. more like this
tabling member constituency Liverpool, Wavertree more like this
tabling member printed
Luciana Berger more like this
uin 12670 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-10-23more like thismore than 2015-10-23
answer text <p><ins class="ministerial">Since 2010 there has been a net reduction in the number of inpatient perinatal mental health beds from 118 beds in 2010 to 115 beds in 2015.</ins></p><p><del class="ministerial">Since 2010 there has been a net reduction of mother and baby units from 17 units to 15 units.</del></p><br /> more like this
answering member constituency North East Bedfordshire more like this
answering member printed Alistair Burt more like this
question first answered
less than 2015-10-23T13:48:26.927Zmore like thismore than 2015-10-23T13:48:26.927Z
question first ministerially corrected
remove maximum value filtermore like thismore than 2015-10-29T10:29:54.26Z
answering member
1201
label Biography information for Alistair Burt more like this
previous answer version
25494
answering member constituency North East Bedfordshire more like this
answering member printed Alistair Burt more like this
answering member
1201
label Biography information for Alistair Burt more like this
tabling member
4036
label Biography information for Luciana Berger more like this
421090
registered interest false more like this
date less than 2015-10-13more like thismore than 2015-10-13
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Mental Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what proportion of people referred for talking therapies received cognitive behaviour therapy in each of the last five years. more like this
tabling member constituency Liverpool, Wavertree more like this
tabling member printed
Luciana Berger more like this
uin 11784 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-10-16more like thismore than 2015-10-16
answer text <p>Information on the proportion of people referred for talking therapies who received cognitive behavioural therapy during 2013/14 is given on the attached table <em>Proportion of Improving Access to Psychological Therapies (IAPT) referrals that finished a course of treatment between 1<sup>st</sup> April 2013 and 31<sup>st</sup> March 2014, for selected therapy types, England</em>. Information for previous years is not available centrally. Information on 2014/15 will be published in November 2015.</p> more like this
answering member constituency North East Bedfordshire more like this
answering member printed Alistair Burt more like this
question first answered
less than 2015-10-16T12:56:33.063Zmore like thismore than 2015-10-16T12:56:33.063Z
question first ministerially corrected
less than 2015-10-16T13:29:49.693Zmore like thismore than 2015-10-16T13:29:49.693Z
answering member
1201
label Biography information for Alistair Burt more like this
attachment
1
file name PQ 11784 IAPT referrals 2013-14.xlsx more like this
title IAPT Referrals for Selected Therapy Types 2013-14 more like this
previous answer version
23809
answering member constituency North East Bedfordshire more like this
answering member printed Alistair Burt more like this
answering member
1201
label Biography information for Alistair Burt more like this
tabling member
4036
label Biography information for Luciana Berger more like this
420822
registered interest false more like this
date less than 2015-09-17more like thismore than 2015-09-17
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Department of Health: Legal Costs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what proportion of his Department's budget is spent on legal fees and damages. more like this
tabling member constituency Warrington South more like this
tabling member printed
David Mowat more like this
uin 901477 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-10-13more like thismore than 2015-10-13
answer text <p>The Departmental Group spend on legal fees is captured in the Annual Report and Accounts for 2014-15. The Departmental Group spend on legal fees is separately identified under Legal Fees in Other Administration Costs,<del class="ministerial"> £61,159k</del> <ins class="ministerial">£61.159 million </ins>and Programme Costs <del class="ministerial">£128,642k,</del> <ins class="ministerial">£128,642 million </ins>totalling <del class="ministerial">£189,801k.</del><ins class="ministerial">£189,801 million.</ins></p><p>The majority of the Core Department’s spend on legal fees is captured as part of ‘Other’ spend under ‘Other Administration Costs’, ‘Programme Costs’ and in “Consultancy services”. The Annual Report and Accounts is available at:</p><p><a href="https://www.gov.uk/government/publications/department-of-health-annual-report-and-accounts-2014-to-2015" target="_blank">https://www.gov.uk/government/publications/department-of-health-annual-report-and-accounts-2014-to-2015</a></p><p>It is intended that from the 2015-16 financial year, spend on legal fees for the core Department will be discussed separately in the accounts.</p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-10-13T16:48:38.747Zmore like thismore than 2015-10-13T16:48:38.747Z
question first ministerially corrected
less than 2015-10-14T14:55:18.47Zmore like thismore than 2015-10-14T14:55:18.47Z
answering member
3918
label Biography information for Jane Ellison more like this
previous answer version
23237
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
4080
label Biography information for David Mowat more like this
416385
registered interest false more like this
date less than 2015-09-04more like thismore than 2015-09-04
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Accident and Emergency Departments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, by what indicators he plans to use to assess the improvement of Trusts receiving support from the Emergency Care Improvement Programme. more like this
tabling member constituency Copeland more like this
tabling member printed
Mr Jamie Reed more like this
uin 8995 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-09-14more like thismore than 2015-09-14
answer text <p><del class="ministerial">Public Health England has developed a campaign to raise awareness of the symptom of breathlessness which ran as a local pilot in Oldham and Rochdale from 24 February – 23 March 2014 and as a regional pilot in the East of England 2 February – 1 March 2015.</del></p><p> </p><p> </p><p> </p><p><del class="ministerial">The Breathlessness campaign aims to encourage those with inappropriate breathlessness (breathlessness that is disproportionate to the level of activity undertaken i.e. at rest or on minimal exertion) to go and see their general practitioner (GP). It is primarily aimed at earlier diagnosis of heart and lung disease, including chronic obstructive pulmonary disease, with scope to reduce premature mortality and to improve the quality of life of those living with these conditions. The key message of the campaign is “If you get out of breath doing things that you used to be able to do, see your GP. Getting out of breath could be a sign of heart or lung disease. Finding it early makes it more treatable, so don’t ignore it, tell your doctor”.</del></p><p> </p><p> </p><p> </p><p><del class="ministerial">Evaluation of the regional pilot is still underway, although early findings from follow-up in-depth interviews with a sample of local GPs and pharmacists and pre and post awareness tracking research among the public, are positive.</del></p><p> </p><p> </p><p><ins class="ministerial"> <p> </p><p><ins class="ministerial">The Emergency Care Improvement Programme (ECIP) is a clinically led programme that will offer practical help and support to the 27 urgent and emergency care systems across England that are under the most pressure. </ins></p><p> </p><p><ins class="ministerial"> </ins></p><p> </p><p><ins class="ministerial">The progress of trusts taking part in ECIP will be measured by monitoring improvements in their accident and emergency (A&amp;E) four hour waiting time standard, along with patient outcome and experience indicators. The urgent and emergency care systems taking part in this programme were selected based on performance against the A&amp;E four hour standard in 2014/15 and Q1 of 2015/16 alongside discussions with regional teams from NHS England, Monitor and the Trust Development Authority.</ins></p><p><ins class="ministerial"> </ins></p></ins></p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-09-14T15:55:26.347Zmore like thismore than 2015-09-14T15:55:26.347Z
question first ministerially corrected
less than 2015-09-14T17:19:34.877Zmore like thismore than 2015-09-14T17:19:34.877Z
answering member
3918
label Biography information for Jane Ellison more like this
previous answer version
21204
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1503
label Biography information for Mr Jamie Reed more like this
390599
registered interest false more like this
date less than 2015-07-16more like thismore than 2015-07-16
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Anaemia more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government what action they are taking to address the problems associated with the late diagnosis of pernicious anaemia, in the light of the results of the survey published in the <i>British Nursing Journal</i> in April 2014. more like this
tabling member printed
The Countess of Mar more like this
uin HL1539 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-07-24more like thismore than 2015-07-24
answer text <p>It is important that patients suffering from pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, receive a prompt and appropriate diagnosis. Pernicious anaemia develops gradually, and can cause a range of symptoms, including fatigue, lethargy, feeling faint and headaches, which vary from patient to patient. Because of the gradual progression of the condition, the variety of symptoms, which are shared with a range of other conditions, diagnosis at early onset can be challenging.</p><p>To support the diagnosis of pernicious anaemia, the British Committee for Standards in Haematology (BCSH) has published <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders,</em> which sets out that cobalamin status is the recommended first line diagnostic test. However, the guidance states that there is no gold standard test for the condition and makes it clear that the clinical picture of a patient is the most important factor in assessing the significance of the test results. This means clinicians should take into account all of the symptoms the patent is experiencing, their medical history, age and other relevant factors when considering the implications of a patient’s cobalamin status. The BCSH guidance highlights the risk of neurological impairment if treatment is delayed.</p><p><br /> The BCSH operates independently of Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate. A copy of the BCSH guidance document <del class="ministerial">has already been placed in the Library and</del> is attached.</p><p><br /> More general clinical guidance on the diagnosis and management of pernicious anaemia can also be found on the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries website. This is a freely accessible online resource that covers the causes, symptoms, diagnosis and treatment of pernicious anaemia, as well as potential complications of the condition. In addition to this, NHS Choices provides similar, though less technical, information on pernicious anaemia for the public.</p>
answering member printed Lord Prior of Brampton more like this
question first answered
less than 2015-07-24T13:21:19.45Zmore like thismore than 2015-07-24T13:21:19.45Z
question first ministerially corrected
less than 2015-10-14T11:21:08.233Zmore like thismore than 2015-10-14T11:21:08.233Z
answering member
127
label Biography information for Lord Prior of Brampton more like this
attachment
1
file name colbalamin and folate disorders.pdf more like this
title BCSH Guidelines pernicious anaemia more like this
previous answer version
17459
answering member printed Lord Prior of Brampton more like this
answering member
127
label Biography information for Lord Prior of Brampton more like this
attachment
1
file name colbalamin and folate disorders.pdf more like this
title BCSH Guidelines pernicious anaemia more like this
tabling member
1861
label Biography information for The Countess of Mar more like this
390600
registered interest false more like this
date less than 2015-07-16more like thismore than 2015-07-16
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Anaemia more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government how they propose to alert medical practitioners to the severe and irreversible nerve damage that can occur when pernicious anaemia is misdiagnosed. more like this
tabling member printed
The Countess of Mar more like this
uin HL1540 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-07-24more like thismore than 2015-07-24
answer text <p>It is important that patients suffering from pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, receive a prompt and appropriate diagnosis. Pernicious anaemia develops gradually, and can cause a range of symptoms, including fatigue, lethargy, feeling faint and headaches, which vary from patient to patient. Because of the gradual progression of the condition, the variety of symptoms, which are shared with a range of other conditions, diagnosis at early onset can be challenging.</p><p>To support the diagnosis of pernicious anaemia, the British Committee for Standards in Haematology (BCSH) has published <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders,</em> which sets out that cobalamin status is the recommended first line diagnostic test. However, the guidance states that there is no gold standard test for the condition and makes it clear that the clinical picture of a patient is the most important factor in assessing the significance of the test results. This means clinicians should take into account all of the symptoms the patent is experiencing, their medical history, age and other relevant factors when considering the implications of a patient’s cobalamin status. The BCSH guidance highlights the risk of neurological impairment if treatment is delayed.</p><p><br /> The BCSH operates independently of Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate. A copy of the BCSH guidance document <del class="ministerial">has already been placed in the Library and</del> is attached.</p><p><br /> More general clinical guidance on the diagnosis and management of pernicious anaemia can also be found on the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries website. This is a freely accessible online resource that covers the causes, symptoms, diagnosis and treatment of pernicious anaemia, as well as potential complications of the condition. In addition to this, NHS Choices provides similar, though less technical, information on pernicious anaemia for the public.</p>
answering member printed Lord Prior of Brampton more like this
question first answered
less than 2015-07-24T13:21:19.357Zmore like thismore than 2015-07-24T13:21:19.357Z
question first ministerially corrected
less than 2015-10-14T11:21:19.847Zmore like thismore than 2015-10-14T11:21:19.847Z
answering member
127
label Biography information for Lord Prior of Brampton more like this
attachment
1
file name colbalamin and folate disorders.pdf more like this
title BCSH Guidelines pernicious anaemia more like this
previous answer version
17460
answering member printed Lord Prior of Brampton more like this
answering member
127
label Biography information for Lord Prior of Brampton more like this
attachment
1
file name colbalamin and folate disorders.pdf more like this
title BCSH Guidelines pernicious anaemia more like this
tabling member
1861
label Biography information for The Countess of Mar more like this
385301
registered interest false more like this
date less than 2015-06-24more like thismore than 2015-06-24
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hepatitis more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government why the national waiting time criterion for referral to hepatitis C treatment is 18 weeks whereas the national waiting time criterion for referral to specialist services for HIV treatment is two weeks. more like this
tabling member printed
Baroness Masham of Ilton more like this
uin HL784 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-07-08more like thismore than 2015-07-08
answer text <p><del class="ministerial">NHS England and Public Health England (PHE) are working alongside a coalition of other organisations and patient groups to draft a framework for hepatitis C improvement. This hepatitis C improvement framework will set high level aims for the public health system towards elimination of hepatitis C related liver disease as a significant public health concern.</del></p><p> </p><p> </p><p> </p><p><del class="ministerial">The hepatitis C improvement framework will be referred to in PHE’s liver disease framework.</del></p><p> </p><p><ins class="ministerial">Timing for access to care or treatments for all NHS England service specifications or policies is based on an assessment of the evidence for clinical effectiveness, cost effectiveness and affordability.</ins></p><p> </p><p> </p> more like this
answering member printed Lord Prior of Brampton more like this
question first answered
less than 2015-07-08T13:53:15.517Zmore like thismore than 2015-07-08T13:53:15.517Z
question first ministerially corrected
less than 2015-07-08T14:59:37.913Zmore like thismore than 2015-07-08T14:59:37.913Z
answering member
127
label Biography information for Lord Prior of Brampton more like this
previous answer version
12907
answering member printed Lord Prior of Brampton more like this
answering member
127
label Biography information for Lord Prior of Brampton more like this
tabling member
1850
label Biography information for Baroness Masham of Ilton more like this
348423
registered interest false more like this
date less than 2015-06-03more like thismore than 2015-06-03
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading General Practitioners more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government what assessment they have made of the results of a survey on behalf of Monitor, which found that one in ten people are dissatisfied with their general practitioner surgery. more like this
tabling member printed
Lord Taylor of Warwick more like this
uin HL235 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-06-17more like thismore than 2015-06-17
answer text <p>On 1 June 2015, Monitor published <em>Improving GP Services: Commissioners and Patient Choice</em>, which included the findings of a nationally representative survey conducted by Ipsos Mori.</p><p> </p><p> </p><p> </p><p>The report noted a high level of satisfaction with general practice overall. It found that 81% of patients were satisfied with their general practitioner (GP) practice, while only 10% were dissatisfied.</p><p> </p><p> </p><p> </p><p>Monitor’s report found that, after location, patients most value the ease of getting an appointment when choosing a GP practice. In order to improve access for patients, the Government has invested £175 million over two years through the Prime Minister’s GP Access Fund. This is testing improved and innovative access to GP services through longer opening hours, such as at evenings and weekends, but also different ways of accessing services, for example the use of Skype consultations. Altogether, there are now 57 schemes covering over 2,500 practices, meaning that over 18 million patients are expected to benefit from improved access and transformational change at local level by March 2016.</p><p>Additionally, the Primary Care Infrastructure Fund is investing £1 billion<ins class="ministerial">, including</ins> <del class="ministerial">and</del> £25 million as part of the Prime Minister’s GP Access Fund, over four years to improve premises and information technology, which will also improve access.</p><p> </p>
answering member printed Lord Prior of Brampton more like this
question first answered
less than 2015-06-17T13:19:17.147Zmore like thismore than 2015-06-17T13:19:17.147Z
question first ministerially corrected
less than 2015-06-19T11:00:07.59Zmore like thismore than 2015-06-19T11:00:07.59Z
answering member
127
label Biography information for Lord Prior of Brampton more like this
previous answer version
5697
answering member printed Lord Prior of Brampton more like this
answering member
127
label Biography information for Lord Prior of Brampton more like this
tabling member
1796
label Biography information for Lord Taylor of Warwick more like this
347943
registered interest false more like this
date less than 2015-06-02more like thismore than 2015-06-02
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Human Papillomavirus: Vaccination more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government, to date, how many adverse reactions to (1) Cervarix, (2) Gardasil and (3) generic human papilloma virus vaccines have been reported to the Medicines and Healthcare products Regulatory Agency; for each category, how many of those reports are of serious adverse reactions; and what age-specific rate those figures represent. more like this
tabling member printed
The Countess of Mar more like this
uin HL229 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-06-16more like thismore than 2015-06-16
answer text <p>A total of 8,243 suspected adverse drug reaction (ADR) reports with human papilloma virus (HPV) vaccines have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA), via the Yellow Card Scheme, up to 3 June 2015.</p><p> </p><p> </p><p> </p><p>To date, more than 8 million doses of HPV vaccine have been given across the United Kingdom as part of the routine immunisation programme. The MHRA does not hold data on age-specific vaccine usage, and therefore age-specific reporting rates cannot be calculated.</p><p> </p><p> </p><p> </p><p>It is important to note that a Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine may have been the cause. Yellow Card data cannot be used as a reliable indicator of the frequency of suspected ADRs to vaccines or medicines. The level of ADR reporting may fluctuate between given years due to a variety of reasons such as a medicine being new (reporting rates are generally higher when a product is first introduced), stimulated interest/publicity and variations in exposure to the medicine.</p><p> </p><p> </p><p> </p><p>The possible known side effects, and the frequency, are listed in the product information which is provided with the vaccines. The vast majority of the 8,243 ADRs relate to the known risks of vaccination that are well-described in the available product information. The proportion of suspected ADRs for HPV vaccines that were reported as serious (32%) is less than the proportion reported as serious for other routinely used vaccines (68% overall) during the same time period. The expected benefits in protecting against HPV-related mortality and disease outweigh the known side effects of HPV vaccine.</p><p> </p><p> </p><p> </p><p>The following table provides a breakdown of UK suspected spontaneous ADRs received via the Yellow Card Scheme in association with the HPV vaccine. The MHRA does not hold data on age-specific vaccine usage, and therefore age-specific reporting rates cannot be calculated.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Vaccine Brand</p></td><td><p>Total number of reports</p></td><td><p>Number of serious reports (% of total)</p></td><td><p>Reporting rate per 1000 doses (serious reporting rates per 1000)</p></td></tr><tr><td><p>Cervarix</p></td><td><p>6,266</p></td><td><p>1,768 (28%)</p></td><td><p><ins class="ministerial">n/a **</ins><del class="ministerial">0.78 (0.22)</del></p></td></tr><tr><td><p>Gardasil</p></td><td><p>1,471</p></td><td><p>504 (34%)</p></td><td><p><ins class="ministerial">n/a **</ins><del class="ministerial">0.18 (0.06)</del></p></td></tr><tr><td><p>HPV Brand unspecified</p></td><td><p>507</p></td><td><p>326 (64%)</p></td><td><p><ins class="ministerial">n/a ** </ins><del class="ministerial">0.06 (0.04)</del></p></td></tr><tr><td><p>Total for Human Papilloma virus vaccines</p></td><td><p>*8,244</p></td><td><p>2,598 (32%)</p></td><td><p>1.03 (0.32)</p></td></tr></tbody></table><p> </p><p><em>Source:</em> MHRA sentinel database for adverse reactions.</p><p> </p><p>* It should be noted that the total number of reports received will not be equal to the totals in the table above as some reports of suspected adverse reactions may have included more than one vaccine.</p><p><ins class="ministerial">**Updated UK-wide brand-specific usage data are not available to MHRA at the time of writing based on a minimum of 8 million combined doses of Cervarix and Gardasil administered across the UK to date.</ins></p><p> </p><p><ins class="ministerial"> <p> </p><p> </p><p> </p></ins></p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The seriousness criteria for ADR reporting were determined by a working group of the Council for International Organizations of Medical Sciences (CIOMS) and are defined as 6 possible categories which are explained on the Yellow Card. The MHRA asks reporters to select one of the following criteria by ticking the appropriate box on the Yellow Card: (1) patient died due to reaction; (2) life threatening; (3) resulted in hospitalisation or prolonged inpatient hospitalisation; (4) congenital abnormality; and (5) involved persistent or significant disability or incapacity; or (6) if the reaction was deemed medically significant. In addition to this, seriousness of reaction terms has also been defined by the MHRA in its medical dictionary. Therefore an ADR report can be serious because the reporter considers the reaction to be serious or because the reaction term itself is considered serious in the MHRA medical dictionary.</p><p> </p>
answering member printed Lord Prior of Brampton more like this
question first answered
less than 2015-06-16T14:35:02.313Zmore like thismore than 2015-06-16T14:35:02.313Z
question first ministerially corrected
less than 2015-07-03T14:01:13.16Zmore like thismore than 2015-07-03T14:01:13.16Z
answering member
127
label Biography information for Lord Prior of Brampton more like this
previous answer version
5462
answering member printed Lord Prior of Brampton more like this
answering member
127
label Biography information for Lord Prior of Brampton more like this
tabling member
1861
label Biography information for The Countess of Mar more like this
224722
registered interest false more like this
date less than 2015-03-03more like thismore than 2015-03-03
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Mid Staffordshire NHS Foundation Trust more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what (a) public dividend capital and (b) other non-tariff payments have been made to the Mid-Stafforshire NHS Foundation Trust in (i) 2009-10, (ii) 2010-11, (iii) 2011-12, (iv) 2012-13, (v) 2013-14 and (vi) 2014-15 to date. more like this
tabling member constituency Stafford more like this
tabling member printed
Jeremy Lefroy more like this
uin 225961 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-03-10more like thismore than 2015-03-10
answer text <p>The Department holds records of the total capital allocated to the respective recipient bodies as a result of the transfer of Mid-Staffordshire NHS Foundation Trust services but does not have details of the breakdown by individual hospital site.</p><p> </p><p> </p><p> </p><p>The capital provided to date is as follows:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>The Royal Wolverhampton NHS Trust</p></td><td><p>£12,109,000</p></td></tr><tr><td><p>University Hospitals of North Midlands NHS Trust</p></td><td><p>£12,153,000</p></td></tr><tr><td><p>Walsall Healthcare NHS Trust</p></td><td><p>£4,000,000</p></td></tr><tr><td><p>Grand Total</p></td><td><p>£28,262,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Revenue funding provided to date is set out in the following table:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p><del class="ministerial">The Royal Wolverhampton NHS Trust</del></p><p><ins class="ministerial">University Hospitals of North Midlands NHS Trust</ins></p><p> </p></td><td><p>£32,420,000</p></td></tr><tr><td><p><del class="ministerial">University Hospitals of North Midlands NHS Trust</del></p><p><ins class="ministerial">The Royal Wolverhampton NHS Trust</ins></p></td><td><p>£5,480,000</p></td></tr><tr><td><p>Grand Total</p></td><td><p>£37,900,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The amount of public dividend capital issued to the Trust by the Department is as follows:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>2009/10</p></td><td><p>£214,000</p></td></tr><tr><td><p>2010/11</p></td><td><p>£0</p></td></tr><tr><td><p>2011/12</p></td><td><p>£21,000,000</p></td></tr><tr><td><p>2012/13</p></td><td><p>£21,385,000</p></td></tr><tr><td><p>2013/14</p></td><td><p>£30,397,000</p></td></tr><tr><td><p>2014/15</p></td><td><p>£64,425,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The Department does not hold central records of non-tariff payments made by local commissioning bodies to NHS providers.</p><p> </p><p> </p><p> </p><p>The work of the trust special administrators (TSAs) to secure safe and sustainable services at Mid Staffordshire NHS Trust cost Monitor almost £19.5 million, including VAT, over 18 months.</p><p> </p><p> </p><p> </p><p>The first phase of trust special administration cost £9 million, including expenses and VAT. During this phase there was a team of up to 30 members of staff who carried out three core tasks - to help to run the Trust, to design the future of services provided at Stafford and Cannock hospitals, and to run a large public consultation involving thousands of responses and a series of public meetings.</p><p> </p><p> </p><p> </p><p>The second phase cost £10.5 million, including expenses and VAT. We are informed by Monitor that this second phase included a team of up to 50 people, which was required to continue to help run the hospital and implement the TSA’s recommendations.</p><p> </p><p> </p><p> </p><p>We are also informed by Monitor that trust special administration at Mid-Staffordshire NHS Trust amounted to the rounded figure of 10,900 person-days for teams working on both phases of the process.</p><p> </p><p> </p><p> </p><p>In the table below, expenses incurred during the TSA process are split by the two phases of the TSA and totals are also provided. These expenses include:</p><p> </p><p> </p><p> </p><p>(a) accommodation;</p><p> </p><p>(b) travel (car, taxi and train);</p><p> </p><p>(c) subsistence; and</p><p> </p><p>(d) other expenses incurred; and what other costs to the TSA were incurred</p><p> </p><p> </p><p> </p><p>Breakdown of expenses, these exclude VAT:</p><p> </p><p> </p><p> </p><table><tbody><tr><td> </td><td><p>TSA1</p></td><td><p>TSA2</p></td><td><p>Total</p></td></tr><tr><td><p>Accommodation</p></td><td><p>£82,242.89</p></td><td><p>£170,622.67</p></td><td><p>£252,865.56</p></td></tr><tr><td><p>Travel</p></td><td><p>£144,122.38</p></td><td><p>£226,600.29</p></td><td><p>£370,722.67</p></td></tr><tr><td><p>Subsistence</p></td><td><p>£16,171.73</p></td><td><p>£43,176.88</p></td><td><p>£59,348.61</p></td></tr><tr><td><p>Other (incidentals such as printing, room hire and meeting refreshments)</p></td><td><p>£1,939.11</p></td><td><p>£3052.73</p></td><td><p>£4991.84</p></td></tr><tr><td><p>Total</p></td><td><p>£244,476.11</p></td><td><p>£443,452.57</p></td><td><p>£687,928.68</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
question first answered
less than 2015-03-10T17:13:10.567Zmore like thismore than 2015-03-10T17:13:10.567Z
question first ministerially corrected
less than 2015-03-17T16:58:22.383Zmore like thismore than 2015-03-17T16:58:22.383Z
answering member
3932
label Biography information for Dr Dan Poulter more like this
previous answer version
49060
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
answering member
3932
label Biography information for Dr Dan Poulter more like this
tabling member
4109
label Biography information for Jeremy Lefroy more like this